Two BSU representatives who attended the Biotechnology Industry Organization (BIO) International Convention in Boston made connections with industry leaders in hopes of opening more research, internship and employment possibilities for undergraduates.
"Everything we do goes back to increasing opportunities for our students," said Dean [b]Arthur Goldstein[/b] of the College of Science and Mathematics, who attended the event with [b]Dr. Joseph Seggio[/b], assistant professor of biology.
Known as the largest biotechnology convention in the world, the four-day conference brought more than 16,500 industry leaders from 65 countries to the Boston Convention and Exhibition Center to build relationships and learn about innovations in the field. Speakers, breakout sessions and forums covered best business practices, financing concerns, manufacturing issues, and more. (For more information on the conference click [link]here|http://convention.bio.org/[/link].)
Sharing the convention's academic section with such PhD-granting institutions as Harvard and MIT, the BSU reps spent their time promoting the notable research done by BSU undergraduates.
"The work our students do is just as important as at the larger universities," said Dean Goldstein, adding, "Those students that go on to earn masters and doctorates and work in the field -- they have to come from somewhere."
Numerous BSU students have gone on to work in the biotechnology industry or enroll in prestigious PhD science programs.
Increasing BSU's visibility at such venues could open many doors for students at prominent pharmaceutical and biotech companies, such as Genzyme and Pfizer, which were represented at the event, as well as at state and federal organizations, said Dean Goldstein. "We're getting the word out," he said. "It's certainly a start."
And with the construction of the $98.7 million Mathematics and Science Center, complete with cutting edge equipment, labs, and a new observatory, BSU is making its mark on the science scene, said Dean Goldstein. "With this building, we're pushing the envelope on research," he said.
Convention guests included Gov. Deval Patrick and keynotes included Senator John Kerry, Christopher Viehbacher, chairman at Genzyme, and former U.S. Secretaries of the Treasury Robert E. Rubin and Henry M. Paulson, Jr., among others.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers, and related organizations in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. (Rob Matheson, '07, G '11, University Advancement)